MedTrace Logo

Comparison of Lipophilic Versus Hydrophilic Statins on Patients With Heart Failure

NCT03255044 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 85

Last updated 2020-01-09

No results posted yet for this study

Summary

There is a controversy whether statins are beneficial in patients with heart failure or not. Trials in which lipophilic statins have been used revealed positive results, unlike major studies where hydrophilic statins were administered. This trial is designed to compare the effects of lipophilic versus hydrophilic statin use in patients with heart failure.

Conditions

Interventions

DRUG

Atorvastatin

Atorvastatin administered as well as standard heart failure therapy

DRUG

Rosuvastatin

Rosuvastatin administered as well as standard heart failure therapy

OTHER

guideline directed therapy

standard heart failure therapy

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-15
Primary Completion
2019-03-01
Completion
2019-04-01

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03255044 on ClinicalTrials.gov